These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21537551)

  • 81. Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region.
    Dagenais R; Wilby KJ; Elewa H; Ensom MHH
    Drugs R D; 2017 Sep; 17(3):341-361. PubMed ID: 28748348
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Fluconazole-induced intoxication with phenytoin in a patient with ultra-high activity of CYP2C9.
    Helldén A; Bergman U; Engström Hellgren K; Masquelier M; Nilsson Remahl I; Odar-Cederlöf I; Ramsjö M; Bertilsson L
    Eur J Clin Pharmacol; 2010 Aug; 66(8):791-5. PubMed ID: 20405111
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics.
    Bae JW; Choi CI; Kim MJ; Oh DH; Keum SK; Park JI; Kim BH; Bang HK; Oh SG; Kang BS; Park HJ; Kim HD; Ha JH; Shin HJ; Kim YH; Na HS; Chung MW; Jang CG; Lee SY
    Acta Pharmacol Sin; 2011 Oct; 32(10):1303-8. PubMed ID: 21841812
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.
    Caudle KE; Rettie AE; Whirl-Carrillo M; Smith LH; Mintzer S; Lee MT; Klein TE; Callaghan JT;
    Clin Pharmacol Ther; 2014 Nov; 96(5):542-8. PubMed ID: 25099164
    [TBL] [Abstract][Full Text] [Related]  

  • 85. HLA-B*51:01 and CYP2C9*3 Are Risk Factors for Phenytoin-Induced Eruption in the Japanese Population: Analysis of Data From the Biobank Japan Project.
    Hikino K; Ozeki T; Koido M; Terao C; Kamatani Y; Mizukawa Y; Shiohara T; Tohyama M; Azukizawa H; Aihara M; Nihara H; Morita E; Murakami Y; Kubo M; Mushiroda T
    Clin Pharmacol Ther; 2020 May; 107(5):1170-1178. PubMed ID: 31646624
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy.
    Guo Y; Hu C; He X; Qiu F; Zhao L
    Drug Metab Pharmacokinet; 2012; 27(5):536-42. PubMed ID: 23099353
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Phenytoin intoxication associated with omeprazole administration in a child with defective CYP2C9.
    Marano M; Nicoletti F; Pro S; Goffredo BM; Cecchetti C; Piervincenzi E; Agolini E; Cocciadiferro D
    Eur J Clin Pharmacol; 2020 May; 76(5):731-732. PubMed ID: 31938857
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.
    Karnes JH; Rettie AE; Somogyi AA; Huddart R; Fohner AE; Formea CM; Ta Michael Lee M; Llerena A; Whirl-Carrillo M; Klein TE; Phillips EJ; Mintzer S; Gaedigk A; Caudle KE; Callaghan JT
    Clin Pharmacol Ther; 2021 Feb; 109(2):302-309. PubMed ID: 32779747
    [TBL] [Abstract][Full Text] [Related]  

  • 89. CYP2C9 allele variants in Chinese hypertension patients and healthy controls.
    Yu BN; Luo CH; Wang D; Wang A; Li Z; Zhang W; Mo W; Zhou HH
    Clin Chim Acta; 2004 Oct; 348(1-2):57-61. PubMed ID: 15369736
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Gender specific association of CYP2C9*3 with hyperlipidaemia in Chinese.
    Luo CH; Wang A; Zhu RH; Zhang WX; Mo W; Yu BN; Chen GL; Ou-Yang DS; Duan XH; Abd El-Aty AM; Zhou HH
    Br J Clin Pharmacol; 2005 Dec; 60(6):629-31. PubMed ID: 16305587
    [TBL] [Abstract][Full Text] [Related]  

  • 91. HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians.
    Su SC; Chen CB; Chang WC; Wang CW; Fan WL; Lu LY; Nakamura R; Saito Y; Ueta M; Kinoshita S; Sukasem C; Yampayon K; Kijsanayotin P; Nakkam N; Saksit N; Tassaneeyakul W; Aihara M; Lin YJ; Chang CJ; Wu T; Hung SI; Chung WH
    Clin Pharmacol Ther; 2019 Feb; 105(2):476-485. PubMed ID: 30270535
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A real-life pilot study of the clinical application of pharmacogenomics testing on saliva in epilepsy.
    Riva A; Roberti R; D'Onofrio G; Vari MS; Amadori E; De Giorgis V; Cerminara C; Specchio N; Pietrafusa N; Tombini M; Assenza G; Cappanera S; Marini C; Rasmini P; Veggiotti P; Zara F; Russo E; Striano P
    Epilepsia Open; 2023 Sep; 8(3):1142-1150. PubMed ID: 36840436
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Association between SCN1A polymorphism and carbamazepine-resistant epilepsy.
    Abe T; Seo T; Ishitsu T; Nakagawa T; Hori M; Nakagawa K
    Br J Clin Pharmacol; 2008 Aug; 66(2):304-7. PubMed ID: 18489610
    [TBL] [Abstract][Full Text] [Related]  

  • 94. CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment.
    Silvado CE; Terra VC; Twardowschy CA
    Pharmgenomics Pers Med; 2018; 11():51-58. PubMed ID: 29636628
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Patient, Disease, and Drug-Related Risk Factors Associated with Phenytoin- Induced Cutaneous Adverse Drug Reactions in South Indian Epileptic Patients - A Prospective Case-Control Study.
    John S; Canyuk B; Anand TCV; Sukasem C; Pattharachayakul S
    Curr Drug Saf; 2022; 17(3):241-249. PubMed ID: 34792004
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Genetic polymorphism of NAT2 metabolizing enzymes on phenytoin pharmacokinetics in Indian epileptic patients developing toxicity.
    Murali M; Manjari T; Madhuri B; Raghavan S; Jain DC; Vivekanandhan S
    CNS Neurosci Ther; 2012 Apr; 18(4):350-8. PubMed ID: 22268821
    [TBL] [Abstract][Full Text] [Related]  

  • 97. How genetic variation was analyzed in phenytoin-induced gingival enlargement using single-nucleotide polymorphism of candidate gene CYP2C9?
    Balakrishnan P; Ramesh V; Balamurali PD; Kennedy Babu SPK; Prasad KV; Gandhimadhi D
    J Oral Maxillofac Pathol; 2020; 24(3):505-509. PubMed ID: 33967488
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Drug-induced gingival overgrowth: the genetic dimension.
    Charles NS; Chavan R; Moon NJ; Nalla S; Mali J; Prajapati A
    N Am J Med Sci; 2014 Sep; 6(9):478-80. PubMed ID: 25317394
    [TBL] [Abstract][Full Text] [Related]  

  • 99. CYP2C9, CYP2C19, and ABCB1 genotype and hospitalization for phenytoin toxicity.
    Hennessy S; Leonard CE; Freeman CP; Metlay JP; Chu X; Strom BL; Bilker WB
    J Clin Pharmacol; 2009 Dec; 49(12):1483-7. PubMed ID: 19617466
    [No Abstract]   [Full Text] [Related]  

  • 100. Nurse empowerment through Pharmacogenetics.
    Moraes JC; Nunes FDD; Coeli-Lacchini FB; Miyazaki AHL; Flória-Santos M; Lacchini R
    Rev Lat Am Enfermagem; 2020; 28():e3265. PubMed ID: 32813781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.